Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00090584 · ClinicalTrials.gov registry record · NA
Behavior Enhances Drug Reduction of Incontinence (BE-DRI)
A NA study, sponsored by Carelon Research.
- Completed
- Registry status
- NA
- Development phase
- 307
- Enrollment target
NCT00090584 is a NA study that has completed, run by Carelon Research. The registered enrollment target is 307 participants.
The verdict
NCT00090584, a NA study, has completed, sponsored by Carelon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 307 participants
- Enrollment target
Study Summary
The primary aim of this study is to test if the addition of behavioral treatment to drug therapy for the treatment of urge incontinence will increase the number of patients who can discontinue drug therapy and sustain a significant reduction of incontinence.
Interventions
- DRUG Tolterodine
- BEHAVIORAL Behavioral training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 307 participants |
| Start Date | 2004-08 |
| Est. Completion | 2006-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00090584
The ClinicalTrials.gov registry entry for NCT00090584 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 307 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carelon Research, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tolterodine is the first listed.
NCT00090584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00090584 about?
NCT00090584 is a clinical study titled "Behavior Enhances Drug Reduction of Incontinence (BE-DRI)". The primary aim of this study is to test if the addition of behavioral treatment to drug therapy for the treatment of urge incontinence will increase the number of patients who can discontinue drug therapy and sustain a significant reduction of incontinence.
What is the current status of trial NCT00090584?
This trial is currently completed. It is a NA study. The enrollment target is 307 participants. The study started on 2004-08. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00090584?
The interventions under investigation include: Tolterodine (DRUG), Behavioral training (BEHAVIORAL).
Who is sponsoring clinical trial NCT00090584?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.